The evolution of the Automated Cell Culture Market region can be attributed to innovations in stem cell research, drug discovery, and higher investments in developing novel products. As per MRFR, the market is estimated to make USD 8,579.8 million and achieve a CAGR of 8.18% by 2027.
Mass production of vaccines and gene therapy is anticipated to drive the market in the forecast period. Stem cell research, tissue engineering, toxicity testing, and regenerative medicine have led to the automated cell culture market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/767
The segmental study of the automated cell culture market has been conducted based on type, application, product, and end-user. The automated cell culture market is classified into tissue engineering & regenerative medicine, biopharmaceutical production, drug screening and development, gene therapy, stem cell research, toxicity testing, and diagnostics based on application. The market has been divided into two type ssegment: entire lab automation and modular automation. The automated cell culture market has been segmented into vessels and consumables based on product. The end-user segment in the market includes diagnostic laboratories, pharmaceuticals, hospitals, cell banks, biotechnology companies, and research institutes.
Detailed Regional Analysis
Owing to the presence of many automated cell culture manufacturers in the region, the Americas region is anticipated to have the greatest share of the global automated cell culture market in the assessment period. The automated cell culture market in Europe is anticipated to grow during the forecast period due to influences such as grown product introduction, expanding government initiatives, and the convenience associated with these products’ improved features. Due to the obtainability of highly skilled people and ease of patient recruitment to perform clinical tests, major biopharmaceutical companies are focusing on conducting clinical trial research in Asian countries. As a result, the region is seeing an increase in research laboratories. The developing number of research facilities and the intensifying demand for novel medicines are anticipated to drive market expansion.
Government assistance is expected to support worldwide market development in the next years. Due to the return of COVID cases in many locations, the market may exhibit constrained growth. The continuation of occasional lockdowns in numerous regions may cause the market expansion to be hampered if resources such as labor and supply chains are severely impacted. The reliance on online commerce for sales is expected to increase significantly during the forecast period, prompting market stakeholders to invest more in its growth. The global market is expected to diversify in operational techniques as innovative models for operation and delivery are implemented. It is projected that the emphasis on accumulating reserves of resources to deal with unexpected crises would impact future market trends. Market developments and research are expected to generate attractive growth opportunities in the next years.
The important companies in the automated cell culture market are F. Hoffmann-La Roche (Switzerland), Siemens Healthcare GmbH (Germany), Thermo Fisher Scientific (US), Sartorius Stedim Biotech Group (Germany), Hitachi, Ltd (Japan), Hamilton Company (US), Beckman Coulter, Inc. (US), Tecan Trading AG (Switzerland), and Becton, Dickinson, and Company.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/automated-cell-culture-market-767
Apr 2021 The Asia-Pacific Advanced Therapy Manufacturing & Innovation (ATMI) Grant Winner from Seoul National University College has been revealed. Terumo Blood and Cell Technologies provided a $50,000 ATMI Grant 2020 to assist the creative discovery of novel applications with the Quantum® Cell Expansion System in the Asia-Pacific area. Terumo Blood and Cell Technologies is a global pioneer in collecting and processing blood and cells. Quantum is a part of the company’s expanding footprint in cell and gene therapy. Quantum is an automated cell culture device meant to minimize labor-intensive manual operations connected with cell culture flasks, improving repeatability and scalability of the cell culture process to fulfill factory-scale needs.
Browse Related Reports at:
Global Bio adhesive Market Research Report – Forecast to 2027
Global Post-Operative Pain Management Market Research Report – Forecast to 2027
Global Neuropsychiatric Disorders and Treatment Market Research Report– Forecast To 2027
Global Optogenetics Market Research Report – Forecast to 2027
Global Apheresis Market Research Report – Forecast To 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071